Additional file 14: Figure S7. of Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
Melissa Quintero
Douglas Adamoski
Larissa Reis
Carolline Ascenção
Krishina Oliveira
Kaliandra Gonçalves
Marília Dias
Marcelo Carazzolle
Sandra Dias
10.6084/m9.figshare.c.3924763_D5.v1
https://springernature.figshare.com/articles/figure/Additional_file_14_Figure_S7_of_Guanylate-binding_protein-1_is_a_potential_new_therapeutic_target_for_triple-negative_breast_cancer/5580928
GO analysis of altered pathways in TNBC tissues and cell lines (compared with non-TNBC samples). Biological processes (blue), cellular components (red) and molecular functions (green) equally enriched in TNBC tissues (left) and cell lines (right). These pathways point to events occurring on the membrane, associated with signaling activity and cell motility. Each box denotes 1 order of magnitude of FDR reduction; dashed black lines highlight an FDR = 0.05 (PNG 1759 kb)
2017-11-07 05:00:00
Breast cancer
Triple-negative breast cancer
Gene expression
RNA-Seq
Transcriptomics
Therapeutic target